BioSpace News Archive

The global DNA synthesis market size was accounted for USD 281.11 million in 2022 and it is predicted to expand around USD 513.80 million by 2030 with a CAGR of 7.83% from 2022 to 2030.

Inspired Spine, a leading innovator in minimally invasive spinal surgery, is thrilled to announce the grand opening of the state-of-the-art “Haring J Nauta” Lab.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for aflibercept 8 mg for the treatment of patients with wet age-related macular degeneration (wAMD), diabetic macular edema (DME) and diabetic retinopathy (DR), solely due to an ongoing review of inspection findings at a third-party filler.

Vernal Biosciences, an innovative mRNA and LNP Contract Development and Manufacturing Organization announced the completion of a $20MM funding round, led by Ampersand Capital Partners and Charles River Labs with participation from Dynamk Capital and the Vermont Center for Emerging Technologies.

NorthStar Medical Radioisotopes, LLC, and Nucleus RadioPharma announced the signing of a supply agreement for the therapeutic radioisotope actinium-225.

AIM ImmunoTech Inc. today announced the required approvals from the Netherlands for Erasmus Medical Center (“Erasmus MC”) to begin a Phase 1b/2 study under the previously announced external sponsored collaborative clinical research agreement with AstraZeneca and Erasmus MC.

Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging, announced the launch of its new pipeline company, Telos Biotech.

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, today is pleased to announce that the Company’s virtual Annual General Meeting of Shareholders (the “AGM”) will be webcast on June 28, 2023, at 4:30 p.m. EDT.

Recurrent bouts of systemic lupus erythematosus, marked by the body’s immune system attack of its own tissues, closely tracked with measureable upticks in growth in the gut of a certain species of bacteria.

Bruker Corporation, the global leader in X-ray diffraction, announces the new D6 PHASERTM X-Ray Diffraction system.